Penn’s one-stop solution for technology commercialization and entrepreneurship
I’m a Faculty Member or Researcher
I’m with a Company
I’m an Entrepreneur
I want to:
Translating Discoveries
PCI helps to translate discoveries and ideas created at the University of Pennsylvania into new products and businesses for societal benefit.
We actively facilitate a broad range of technology development connections between Penn and the private sector. Whether the end result is a technology license, an R&D alliance, or the formation of a new venture, PCI serves as a dedicated one-stop shop for commercial partnering with Penn.
Access the FY2025 Year in Review
#1
in licensing revenue 5th year in a row
26
Startups launched
>$591M
in investment capital raised or received by Penn affiliated startups
99
New patents awarded
Join PCI in San Francisco this January
PCI is hosting our Innovation @ Penn program in San Francisco on January 12, 2026, at 3 pm. This signature event, held concurrently during the annual JP Morgan Healthcare Conference, is an excellent opportunity to learn about emerging areas of innovation and opportunities for partnership with Penn. The program attracts professionals from across the life science industry, the investor community, and other stakeholders, and provides a platform for in-depth discussions about emerging healthcare technologies and their practical applications.
PCI is honored to have an outstanding group of participants, including leading luminaries:
- Peter Marks, MD, PhD, Senior Vice President of Molecule Discovery & Head of Infectious Disease at Eli Lilly, and former Director of the FDA’s Center for Biologics Evaluation and Research
- Jim Wilson, MD, PhD, Emeritus Professor of Medicine (Translation of Medicine and Human Genetics) at Penn Medicine, Founder and CEO of Gemma Biotherapeutics, and Founder and Executive Chair of Franklin Biolabs
- Allison Rae Greenplate, PhD, Adjunct Assistant Professor of Systems Pharmacology and Translational Therapeutics and Director of Immune Health at Penn Medicine
- Laura Shawver, PhD, former President and CEO of Capstan Therapeutics, will serve as moderator of the panel
- Jonathan Epstein, MD, PhD, Dean, Perelman School of Medicine and Executive Vice President of the University of Pennsylvania for the Health System, will deliverkeynote remarks
More details and registration information can be found below. Please join us!
Read the latest news from PCI here:
PCI’s New Technology LinkedIn Page
PCI recently launched a new LinkedIn page showcasing our technologies that are currently available for investment and partnership opportunities. Follow here.
Available Technologies
Find technology opportunities by sector or search:
Nanotechnology | Antibody | Optics & Photonics | Medical Devices | COVID-19 | Immunology | Oncology | Materials | Bioengineering | Neurodegenerative Diseases
View all technologies
Recent News
All NewsCapstan Therapeutics Acquired by AbbVie for $2.1B
Penn Medicine’s Kiran Musunuru Featured in The New York Times for Gene Therapy Breakthrough
Penn Engineering’s Liang Feng Conducts Promising Research on Nonlinear Neural Networks to Train AI on Lightspeed
New Tools for Treating Advanced Retinal Degenerations Developed by Penn Vet Researchers
Discover CAR T-cell technology at Penn
Our latest CAR T-cell enhancement portfolio features innovations poised to transform treatment efficacy with boosted cytokine activity/metabolism, streamlined manufacturing, and reduced T-cell exhaustion. Join us in turning lab discoveries into real-world impact through licensing opportunities with PCI.
Upcoming Events
All Events